Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults
Condition: NorovirusInterventions: Biological: Norovirus Bivalent VLP Vaccine; Drug: Placebo (Saline); Biological: Norovirus Bivalent VLP VaccineSponsor: TakedaNot yet recruiting - verified May 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials